Vergara Monica, Hauser Michelle E, Aronica Lucia, Rigdon Joseph, Fielding-Singh Priya, Shih Cynthia W, Gardner Christopher D
Department of Health Research & Policy, Stanford University School of Medicine, Stanford, CA 94305, USA.
General Surgery, Department of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USA.
Nutrients. 2021 Jun 4;13(6):1935. doi: 10.3390/nu13061935.
In 2015, the Dietary Guidelines for Americans (DGA) eliminated the historical upper limit of 300 mg of dietary cholesterol/day and shifted to a more general recommendation that cholesterol intake should be limited. The primary aim of this secondary analysis of the Diet Intervention Examining the Factors Interacting With Treatment Success (DIETFITS) weight loss diet trial was to evaluate the associations between 12-month changes in dietary cholesterol intake (mg/day) and changes in plasma lipids, particularly low-density lipoprotein (LDL) cholesterol for those following a healthy low-carbohydrate (HLC) diet. Secondary aims included examining high-density lipoprotein (HDL) cholesterol and triglycerides and changes in refined grains and added sugars. The DIETFITS trial randomized 609 healthy adults aged 18-50 years with body mass indices of 28-40 kg/m to an HLC or healthy low-fat (HLF) diet for 12 months. Linear regressions examined the association between 12-month change in dietary cholesterol intake and plasma lipids in 208 HLC participants with complete diet and lipid data, adjusting for potential confounding variables. Baseline dietary cholesterol intake was 322 ± 173 (mean ± SD). At 12 months, participants consumed an average of 460 ± 227 mg/day of dietary cholesterol; 76% consumed over the previously recommended limit of 300 mg/day. Twelve-month changes in cholesterol intake were not significantly associated with 12-month changes in LDL-C, HDL-C, or triglycerides. Diet recall data suggested participants' increase in dietary cholesterol was partly due to replacing refined grains and sugars with eggs. An increase in daily dietary cholesterol intake to levels substantially above the previous 300 mg upper limit was not associated with a negative impact on lipid profiles in the setting of a healthy, low-carbohydrate weight loss diet.
2015年,《美国膳食指南》取消了每日膳食胆固醇300毫克的历史上限,转而提出更一般性的建议,即应限制胆固醇摄入量。本次对饮食干预研究治疗成功相关因素(DIETFITS)减肥饮食试验的二次分析的主要目的是评估膳食胆固醇摄入量(毫克/天)的12个月变化与血浆脂质变化之间的关联,特别是对于遵循健康低碳水化合物(HLC)饮食的人群,评估其与低密度脂蛋白(LDL)胆固醇变化的关联。次要目的包括研究高密度脂蛋白(HDL)胆固醇、甘油三酯以及精制谷物和添加糖的变化。DIETFITS试验将609名年龄在18至50岁之间、体重指数为28至40千克/平方米的健康成年人随机分为HLC饮食组或健康低脂(HLF)饮食组,为期1年。线性回归分析了208名有完整饮食和脂质数据的HLC参与者中,膳食胆固醇摄入量的12个月变化与血浆脂质之间的关联,并对潜在的混杂变量进行了调整。基线膳食胆固醇摄入量为322±173(平均值±标准差)。在12个月时,参与者平均每日摄入膳食胆固醇460±227毫克;76%的人摄入量超过了之前建议的300毫克/天的上限。胆固醇摄入量的12个月变化与LDL-C、HDL-C或甘油三酯的12个月变化无显著关联。饮食回忆数据表明,参与者膳食胆固醇的增加部分是由于用鸡蛋替代了精制谷物和糖类。在健康的低碳水化合物减肥饮食背景下,每日膳食胆固醇摄入量大幅增加至远超之前300毫克上限的水平,并未对血脂谱产生负面影响。